BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33414415)

  • 21. Major vault protein suppresses lung cancer cell proliferation by inhibiting STAT3 signaling pathway.
    Bai H; Wang C; Qi Y; Xu J; Li N; Chen L; Jiang B; Zhu X; Zhang H; Li X; Yang Q; Ma J; Xu Y; Ben J; Chen Q
    BMC Cancer; 2019 May; 19(1):454. PubMed ID: 31092229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AKR1C1 Activates STAT3 to Promote the Metastasis of Non-Small Cell Lung Cancer.
    Zhu H; Chang LL; Yan FJ; Hu Y; Zeng CM; Zhou TY; Yuan T; Ying MD; Cao J; He QJ; Yang B
    Theranostics; 2018; 8(3):676-692. PubMed ID: 29344298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of Stat3 activity sensitizes gefitinib-resistant non small cell lung cancer cells.
    Chiu HC; Chou DL; Huang CT; Lin WH; Lien TW; Yen KJ; Hsu JT
    Biochem Pharmacol; 2011 Jun; 81(11):1263-70. PubMed ID: 21406185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MiR-147a mediated by sodium new houttuyfonate could enhance radiosensitivity of non-small cell lung cancer cells via suppressing STAT3.
    Dai K; Chen L; Liu J; Ding Y; Gu C; Lu X
    Adv Clin Exp Med; 2021 Feb; 30(2):173-181. PubMed ID: 33650331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SphK1 promotes development of non‑small cell lung cancer through activation of STAT3.
    Ma Y; Xing X; Kong R; Cheng C; Li S; Yang X; Li S; Zhao F; Sun L; Cao G
    Int J Mol Med; 2021 Jan; 47(1):374-386. PubMed ID: 33236138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclosporine A sensitizes human non-small cell lung cancer cells to gefitinib through inhibition of STAT3.
    Shou J; You L; Yao J; Xie J; Jing J; Jing Z; Jiang L; Sui X; Pan H; Han W
    Cancer Lett; 2016 Aug; 379(1):124-33. PubMed ID: 27264264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
    Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
    Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TPPP3 Promotes Cell Proliferation, Invasion and Tumor Metastasis via STAT3/ Twist1 Pathway in Non-Small-Cell Lung Carcinoma.
    Li Y; Bai M; Xu Y; Zhao W; Liu N; Yu J
    Cell Physiol Biochem; 2018; 50(5):2004-2016. PubMed ID: 30404076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Periostin Contributes to Cisplatin Resistance in Human Non-Small Cell Lung Cancer A549 Cells via Activation of Stat3 and Akt and Upregulation of Survivin.
    Hu W; Jin P; Liu W
    Cell Physiol Biochem; 2016; 38(3):1199-208. PubMed ID: 26982182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concomitant overexpression of EGFR and CXCR4 is associated with worse prognosis in a new molecular subtype of non-small cell lung cancer.
    Al Zobair AA; Al Obeidy BF; Yang L; Yang C; Hui Y; Yu H; Zheng F; Yang G; Xie C; Zhou F; Zhou Y
    Oncol Rep; 2013 Apr; 29(4):1524-32. PubMed ID: 23443279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C-X-C motif chemokine receptor 4 promotes tumor angiogenesis in gastric cancer via activation of JAK2/STAT3.
    Zhang Q; Xu F; Shi Y; Chen YW; Wang HP; Yu X; Li Y
    Cell Biol Int; 2017 Aug; 41(8):854-862. PubMed ID: 28544312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-125a regulates HAS1 and inhibits the proliferation, invasion and metastasis by targeting STAT3 in non-small cell lung cancer cells.
    Huang H; Huang J; Yao J; Li N; Yang Z
    J Cell Biochem; 2020 Jun; 121(5-6):3197-3207. PubMed ID: 31930562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physalin A exerts anti-tumor activity in non-small cell lung cancer cell lines by suppressing JAK/STAT3 signaling.
    Zhu F; Dai C; Fu Y; Loo JF; Xia D; Gao SP; Ma Z; Chen Z
    Oncotarget; 2016 Feb; 7(8):9462-76. PubMed ID: 26843613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinome profiling of non-canonical TRAIL signaling reveals RIP1-Src-STAT3-dependent invasion in resistant non-small cell lung cancer cells.
    Azijli K; Yuvaraj S; Peppelenbosch MP; Würdinger T; Dekker H; Joore J; van Dijk E; Quax WJ; Peters GJ; de Jong S; Kruyt FA
    J Cell Sci; 2012 Oct; 125(Pt 19):4651-61. PubMed ID: 22797920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of IL-6R/JAK1/STAT3 signaling induces de novo resistance to irreversible EGFR inhibitors in non-small cell lung cancer with T790M resistance mutation.
    Kim SM; Kwon OJ; Hong YK; Kim JH; Solca F; Ha SJ; Soo RA; Christensen JG; Lee JH; Cho BC
    Mol Cancer Ther; 2012 Oct; 11(10):2254-64. PubMed ID: 22891040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. STAT3-induced long noncoding RNA LINC00668 promotes migration and invasion of non-small cell lung cancer via the miR-193a/KLF7 axis.
    An YX; Shang YJ; Xu ZW; Zhang QC; Wang Z; Xuan WX; Zhang XJ
    Biomed Pharmacother; 2019 Aug; 116():109023. PubMed ID: 31150989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circ_0076305 regulates cisplatin resistance of non-small cell lung cancer via positively modulating STAT3 by sponging miR-296-5p.
    Dong Y; Xu T; Zhong S; Wang B; Zhang H; Wang X; Wang P; Li G; Yang S
    Life Sci; 2019 Dec; 239():116984. PubMed ID: 31647948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination of Huanglian Jiedu Decoction and erlotinib delays growth and improves sensitivity of EGFR‑mutated NSCLC cells in vitro and in vivo via STAT3/Bcl‑2 signaling.
    Zhou X; Liu B; Ning Q; Xia Z; Zhong R; Zhang L; Wu L
    Oncol Rep; 2021 Jan; 45(1):217-229. PubMed ID: 33200228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Γ-Ionizing radiation-induced activation of the EGFR-p38/ERK-STAT3/CREB-1-EMT pathway promotes the migration/invasion of non-small cell lung cancer cells and is inhibited by podophyllotoxin acetate.
    Cho JH; Hong WG; Jung YJ; Lee J; Lee E; Hwang SG; Um HD; Park JK
    Tumour Biol; 2016 Jun; 37(6):7315-25. PubMed ID: 26671552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A meta-analysis for CXCR4 as a prognostic marker and potential drug target in non-small cell lung cancer.
    Zhang C; Li J; Han Y; Jiang J
    Drug Des Devel Ther; 2015; 9():3267-78. PubMed ID: 26150700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.